MedTrace Logo

Multi-center Trial of ValveClamp

NCT03869164 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2020-05-27

No results posted yet for this study

Summary

The ValveClamp (Hanyu Medical Technology, Shanghai, China) is the first edge-to-edge mitral valve repair system for interventional operation in China, which is composed of the front clamp, the rear clamp and the closed ring. The purpose of the multi-center trial is to evaluate the safety and efficacy of the ValveClamp for degenerative mirtal regurgistation.

Conditions

  • Evaluate the Safety and Efficacy of the ValveClamp

Interventions

DEVICE

ValveClamp

ValveClamp is an easy-to-operate transcatheter edge-to-edge mitral valve repair system with larger coaptation width

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Wenzhi Pan, M.D. · Department of Cardiology, Zhongshan Hospital, Fudan University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-12
Primary Completion
2021-12-13
Completion
2025-12-08

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03869164 on ClinicalTrials.gov